2013/03/12
Michael A. Morse will present, “Reporting and Returning Medicare Overpayments: The 60-day Rule and False Claims Act Liability,” at PBI’s 19th Annual Health Law Institute at the Philadelphia Convention Center in Philadelphia, PA on March 12-13, 2013. Related Information: Program Information
February 12, 2013
Joseph D. Mancano will present, “The False Claims Act,” at the Chester County Bar Association’s CLE in Chester County, PA on February 12, 2013.
February 8, 2013
Michael A. Morse will present, “Anatomy of a Whistleblower Case,” at HCCA’s South Atlantic Regional Annual Conference in Orlando, FL on February 8, 2013. Related Information: Program Information
January 24, 2013
Email SLB@Pietragallo.com to register.
January 24, 2013
Philadelphia, Thursday, January 24, 2013: A federal lawsuit filed by prominent Delaware Valley cardiologist Nicholas L. DePace, M.D., sparked a multi-year investigation by the United States Department of Justice and the New Jersey Attorney General’s Office that has resulted in New-Jersey based Cooper Health System, and Cooper University Hospital paying $12,600,000 to settle Medicare and… Read more »
January 14, 2013
On December 20, 2012, in the first major decision regarding the massive Medicare Part D program under the Federal False Claims Act (“FCA”), Judge Ronald Buckwalter denied CVS-Caremark’s motion to dismiss in U.S. ex rel. Spay v. CVS-Caremark, Corp., 2:09-cv-04672-RB (E.D. Pa). The whistleblower lawsuit was filed by an industry insider and licensed pharmacist, Anthony Spay, who alleged that… Read more »
December 7, 2012
Michael A. Morse will present, “False Claims and Overpayment Rule,” at AHLA’s Audits, Self-Disclosures, Recoupment & False Claims Bootcamp Webinar Series, Part II in Philadelphia, PA on December 7, 2012.
November 27, 2012
Marc S. Raspanti and Pamela C. Brecht will present, “North Carolina False Claims Act (WEBCAST),” at the North Carolina Bar Association CLE Program on November 27, 2012. Related Information: Program Information
November 6, 2012
Michael A. Morse will participate on the panel, “Leading Qui Tam Counsel,” at the Thirteenth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum at the Grand Hyatt in Washington, DC on November 6, 2012. Related Information: Program Information
October 4, 2012
Background On September 5, 2012, the Second Circuit issued its decision in U.S. ex rel. Feldman v. Van Gorp., 2012 U.S. App. LEXIS 18667 (2nd Cir. Sept. 5, 2012), a case with important implications for the “materiality” standard under the False Claims Act (“FCA”) as well as the issue of how to properly calculate FCA damages. This… Read more »